CHICAGO (June 12, 2012) Hospitalization rates in New York City for patients with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), a potentially deadly bacterial infection that is resistant to antibiotic treatment, more than tripled between 1997 and 2006, according to a report published in the July issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Most cases of MRSA are acquired in hospitals, nursing homes, or other healthcare facilities. But in recent years public health experts have become increasingly concerned about MRSA infections acquired in community settings like homes, schools, and neighborhoods.
During the study period 3,579 people were admitted to New York City hospitals with CA-MRSA. The rate of CA-MRSA increased from 113 people in 1997, a rate of about 1.5 cases per 100,000 people, to 875 admissions in 2006, a rate of 5.3 per 100,000. Overall, about 20 percent of all MRSA hospitalizations over the study period were community acquired, the study found.
"These findings suggest a substantial increase in the rate of hospitalization with community-acquired MRSA in New York City since 1997," said Amanda Farr, MPH, one of the study's authors. This research was done in collaboration between the New York City Department of Health and Mental Hygiene and Columbia University's Mailman School of Public Health.
When compared with other hospitalizations in the study period, researchers noted that men, children, people with diabetes, people with HIV, and the homeless were more likely to be hospitalized with CA-MRSA than the general population. Residents of the Bronx also had substantially higher rates of CA-MRSA hospitalization than those of other New York City boroughs, likely impacted by a lack of access to primary care health services.
The authors speculated at the increased risk associated with these demographics
|Contact: Tamara Moore|
Society for Healthcare Epidemiology of America